Generate Biomedicines
Open
$12.76
Prev. Close
$12.76
High
$12.76
Low
$12.76
Market Snapshot
$1.58B
312
Generate Biomedicines Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Somerville, Massachusetts and currently employs 312 full-time employees. The company went IPO on 2026-02-27. Generate Biomedicines Inc is a United States-based biotechnology company. The firm uses machine learning (ML) and generative artificial intelligence (AI) to create novel, protein-based therapeutic candidates on demand. Its platform designs, simulates, and optimizes custom proteins such as antibodies, enzymes, and peptides to target specific diseases. The company also focuses on creating faster and better-targeted treatments for various diseases, including oncology, immunology and infectious diseases.
emptyResult
Generate Biomedicines Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Somerville, Massachusetts and currently employs 312 full-time employees. The company went IPO on 2026-02-27. Generate Biomedicines Inc is a United States-based biotechnology company. The firm uses machine learning (ML) and generative artificial intelligence (AI) to create novel, protein-based therapeutic candidates on demand. Its platform designs, simulates, and optimizes custom proteins such as antibodies, enzymes, and peptides to target specific diseases. The company also focuses on creating faster and better-targeted treatments for various diseases, including oncology, immunology and infectious diseases.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.